Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730990 · ClinicalTrials.gov registry record · Phase 1
A Phase I, Healthy Volunteer Positron Emission Tomography Study
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00730990: Completed Phase 1 study, sponsored by Pfizer.
NCT00730990 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00730990, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess central receptor occupancy of PF 03654746 at the H3 receptor after a single oral dose of PF 03654746.
Interventions
- OTHER Positron Emission tomography
- DRUG PET Scan with PF-03654746
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
What the finished NCT00730990 record still lists
NCT00730990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Positron Emission tomography is the first listed.
NCT00730990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00730990 about?
NCT00730990 is a clinical study titled "A Phase I, Healthy Volunteer Positron Emission Tomography Study". The primary purpose of this study is to assess central receptor occupancy of PF 03654746 at the H3 receptor after a single oral dose of PF 03654746.
What is the current status of trial NCT00730990?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-05. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00730990?
The interventions under investigation include: Positron Emission tomography (OTHER), PET Scan with PF-03654746 (DRUG).
Who is sponsoring clinical trial NCT00730990?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00730990's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia